New York State Common Retirement Fund
IMVT icon

New York State Common Retirement Fund’s Immunovant IMVT Stock Holding History

New York State Common Retirement Fund’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
30,055
+4,400
+17% +$134K ﹤0.01% 1686
2026
Q1 		$637K Buy
25,655
+1,600
+7% +$41.4K ﹤0.01% 1820
2025
Q4 		$611K Buy
24,055
+3,800
+19% +$84.7K ﹤0.01% 1890
2025
Q3 		$327K Hold
20,255
– – ﹤0.01% 2092
2025
Q2 		$324K Hold
20,255
– – ﹤0.01% 2064
2025
Q1 		$346K Hold
20,255
– – ﹤0.01% 2013
2024
Q4 		$502K Hold
20,255
– – ﹤0.01% 1940
2024
Q3 		$577K Sell
20,255
-3,600
-15% -$106K ﹤0.01% 1890
2024
Q2 		$630K Sell
23,855
-20,081
-46% -$571K ﹤0.01% 1953
2024
Q1 		$1.42M Buy
43,936
+5,005
+13% +$183K ﹤0.01% 1607
2023
Q4 		$1.64M Buy
38,931
+9,020
+30% +$332K ﹤0.01% 1549
2023
Q3 		$1.15M Buy
29,911
+8,470
+40% +$191K ﹤0.01% 1681
2023
Q2 		$407K Sell
21,441
-448
-2% -$8.36K ﹤0.01% 2187
2023
Q1 		$339K Sell
21,889
-3,154
-13% -$54.7K ﹤0.01% 2371
2022
Q4 		$445K Sell
25,043
-13
-0.1% -$164 ﹤0.01% 2367
2022
Q3 		$140K Buy
25,056
+67
+0.3% +$328 ﹤0.01% 2903
2022
Q2 		$97K Sell
24,989
-42
-0.2% -$181 ﹤0.01% 3070
2022
Q1 		$138K Hold
25,031
– – ﹤0.01% 2946
2021
Q4 		$213K Sell
25,031
-64
-0.3% -$528 ﹤0.01% 2850
2021
Q3 		$218K Buy
25,095
+92
+0.4% +$830 ﹤0.01% 2876
2021
Q2 		$264K Sell
25,003
-8,797
-26% -$123K ﹤0.01% 2920
2021
Q1 		$542K Hold
33,800
– – ﹤0.01% 2413
2020
Q4 		$1.56M Buy
33,800
+2,200
+7% +$102K ﹤0.01% 1808
2020
Q3 		$1.11M Buy
31,600
+14,100
+81% +$424K ﹤0.01% 1856
2020
Q2 		$426K Buy
+17,500
New +$375K ﹤0.01% 2299

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's IMVT Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Immunovant (IMVT) stake by 17% in Q2 2026, buying an estimated $134K and bringing the position to 30,055 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

New York State Common Retirement Fund first reported a position in IMVT in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.64M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • New York State Common Retirement Fund held 30,055 shares of Immunovant worth $1.16M as of Q2 2026.
  • New York State Common Retirement Fund bought 4,400 Immunovant shares in Q2 2026, an estimated $134K.
  • Immunovant made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1686 holding.
  • New York State Common Retirement Fund first reported a position in Immunovant in Q2 2020 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Immunovant position peaked at $1.64M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.